Press/Media

Journal Publications and Media Stories Featuring Neovasc and Our Work in Tissue Supply, Refractory Angina Treatment, and Transcatheter Mitral Valve Replacement (TMVR)

European Heart Journal

The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives

JACC: Cardiovascular Interventions

First Experience With the Coronary Sinus Reducer System for the Management of Refractory Angina in Patients Without Obstructive Coronary Artery Disease

LHSC first in Ontario to implant Canadian made mitral valve device

The cardiac team at London Health Sciences Centre (LHSC) is the first in Ontario to implant the Canadian made Neovasc Tiara transcatheter device to correct a leaky mitral valve.

Cardiology in Review

Narrowing of the coronary sinus, a device based therapy for angina pectoris

Danny Dvir EuroIntervention

Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation

Reducer UMCU Experience

Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: A single-centre real-world experience

The New England Journal of Medicine

Neovasc Reducer: Positive results from the COSIRA Clinical Study

Data confirm the Neovasc reducer improves functional capabilities in refractory angina patients 

Neovasc soars on 1st-in-human implant of Tiara transcatheter mitral valve

Transcatheter treatment for refractory angina with the coronary sinus Reducer

Trans Apical Mitral Implantation (TAMI) of the Tiara TM Bio-prosthesis: Pre-Clinical Results

Tiara: A Novel Catheter-Based Mitral Valve Bioprosthesis
Initial Experiments and Short-Term Pre-Clinical Results

Study published on the Reducer stent for the Treatment of Chronic Refractory Angina Pectoris: Abstract   |  Full study